enVVeno Medical Statistics
Total Valuation
enVVeno Medical has a market cap or net worth of $87.38 million. The enterprise value is $53.89 million.
Important Dates
The last earnings date was Thursday, July 31, 2025, before market open.
| Earnings Date | Jul 31, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
enVVeno Medical has 19.25 million shares outstanding. The number of shares has increased by 44.69% in one year.
| Current Share Class | 19.25M |
| Shares Outstanding | 19.25M |
| Shares Change (YoY) | +44.69% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.84% |
| Owned by Institutions (%) | 20.46% |
| Float | 19.09M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.67 |
| P/TBV Ratio | 2.67 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.81, with a Debt / Equity ratio of 0.03.
| Current Ratio | 11.81 |
| Quick Ratio | 11.66 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -64.55% and return on invested capital (ROIC) is -40.67%.
| Return on Equity (ROE) | -64.55% |
| Return on Assets (ROA) | -38.59% |
| Return on Invested Capital (ROIC) | -40.67% |
| Return on Capital Employed (ROCE) | -71.35% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$623,459 |
| Employee Count | 37 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -8.40% in the last 52 weeks. The beta is 1.01, so enVVeno Medical's price volatility has been similar to the market average.
| Beta (5Y) | 1.01 |
| 52-Week Price Change | -8.40% |
| 50-Day Moving Average | 4.41 |
| 200-Day Moving Average | 3.46 |
| Relative Strength Index (RSI) | 48.59 |
| Average Volume (20 Days) | 165,476 |
Short Selling Information
The latest short interest is 546,119, so 2.84% of the outstanding shares have been sold short.
| Short Interest | 546,119 |
| Short Previous Month | 462,837 |
| Short % of Shares Out | 2.84% |
| Short % of Float | 2.86% |
| Short Ratio (days to cover) | 4.08 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -23.95M |
| Pretax Income | -20.60M |
| Net Income | -23.07M |
| EBITDA | -23.79M |
| EBIT | -23.95M |
| Earnings Per Share (EPS) | -$1.20 |
Full Income StatementBalance Sheet
The company has $35.14 million in cash and $882,000 in debt, giving a net cash position of $34.26 million or $1.78 per share.
| Cash & Cash Equivalents | 35.14M |
| Total Debt | 882,000 |
| Net Cash | 34.26M |
| Net Cash Per Share | $1.78 |
| Equity (Book Value) | 33.06M |
| Book Value Per Share | 1.72 |
| Working Capital | 32.59M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$17.11 million and capital expenditures -$18,000, giving a free cash flow of -$17.13 million.
| Operating Cash Flow | -17.11M |
| Capital Expenditures | -18,000 |
| Free Cash Flow | -17.13M |
| FCF Per Share | -$0.89 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
